JPH06181718A - Enteral nutrient - Google Patents

Enteral nutrient

Info

Publication number
JPH06181718A
JPH06181718A JP4340619A JP34061992A JPH06181718A JP H06181718 A JPH06181718 A JP H06181718A JP 4340619 A JP4340619 A JP 4340619A JP 34061992 A JP34061992 A JP 34061992A JP H06181718 A JPH06181718 A JP H06181718A
Authority
JP
Japan
Prior art keywords
purified protein
protein
enteral
vitamin
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4340619A
Other languages
Japanese (ja)
Inventor
Shigeo Sotozono
茂生 外薗
Mitsuo Emoto
三男 江本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP4340619A priority Critical patent/JPH06181718A/en
Publication of JPH06181718A publication Critical patent/JPH06181718A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To provide an enteral nutrient containing a purified protein of kacang hijiau (Phaseolus radiatus L.) in a prescribed amount, not giving side effects, capable of be applied also to the case of lactose intolerance, excellent in its nutritive value and digestive absorption property, and suitable for the control of nutrients in hospitals, etc. CONSTITUTION:The objective enteral nutrient comprises the purified protein of the kacang hijiau in an amount of 1-20wt.% based on its dry weight, preferably 40-95wt.% of a carbohydrate such as glucose 0-20wt.% of a fat or oil such as corn oil, and 5-40wt.% of the total proteins including the purified protein of the kacang hijiau, all of the amounts being based on their dry weights. The nutrient is administered preferably at a dose of 20-35ml/kg. a day for an adult in the liquid form of 25%(W/V%).

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は新規な精製蛋白質を利用
した経腸栄養剤に関する。
FIELD OF THE INVENTION The present invention relates to an enteral nutritional supplement utilizing a novel purified protein.

【0002】[0002]

【従来技術とその課題】カチャンヒジャ(Kacang Hijia
u 、学名:ファセオラス ラジアタス:Phaseolus Radi
atus L. )は、主にインドネシアで採れる緑豆(Green
gram乃至Mungbeans )の一種であり、現地では該豆の粉
末を、水に溶解して飲料としたり、他の食物にふりかけ
て食用している。一方、病院では患者の栄養管理に関し
て流動食が主体であり、経腸栄養乃至経鼻・経口栄養剤
は、ミルクカゼインを主体とした製品が一部利用されて
いるに過ぎず、満足のいく栄養管理が成されていない現
状にある。また、インドネシアでは一般に小児が牛乳を
摂取できる機会は少なく、乳糖不耐症のケースもかなり
認められる現状にある。
[Prior art and its problems] Kacang Hijia
u, Scientific name: Phaseolus Radius
atus L.) is a green bean produced mainly in Indonesia (Green
gram or Mungbeans), and locally, the bean powder is dissolved in water to be used as a drink or sprinkled on other foods for consumption. On the other hand, in hospitals, liquid nutrition is the main source of nutritional management for patients, and for enteral nutrition, nasal and oral nutritional products, milk casein-based products are only partially used. It is in the present condition that management is not done. Moreover, in Indonesia, there are generally few opportunities for children to eat milk, and there are many cases of lactose intolerance.

【0003】こうした現状を踏まえ、インドネシアの小
児の栄養管理に見合う蛋白質の供給が現在最も注目され
る課題の一つとして挙げられる。
In view of the current situation, the supply of proteins commensurate with nutritional management of Indonesian children can be cited as one of the most noticeable issues at present.

【0004】本発明者らは、上記課題を解決する観点か
ら鋭意研究を重ねる過程において、インドネシア産の上
記カチャンヒジャに着目し、その蛋白質を精製した結
果、該蛋白質が上記目的に合致する優れた栄養価その他
の性質を有すると共に、これが経腸栄養剤(経鼻・経口
栄養剤を含む)の蛋白源として好適であり、その利用に
よれば、乳糖不耐症のケースにも有利に適用でき、病院
での栄養管理に満足できる栄養改善効果を奏し得る目的
の経腸栄養剤が提供されることを見出した。
The present inventors focused their attention on the above-mentioned Kachanghija produced in Indonesia in the course of earnest research from the viewpoint of solving the above-mentioned problems, and as a result of purifying the protein, the excellent nutrition that the protein meets the above-mentioned purpose. It has valency and other properties, and is suitable as a protein source for enteral nutritional products (including nasal and oral nutritional products), and its use can be advantageously applied to cases of lactose intolerance, It has been found that an enteral nutritional supplement for the purpose of providing a nutritional improvement effect that is satisfactory for nutritional management in a hospital is provided.

【0005】本発明は上記知見に基づいて完成されたも
のである。
The present invention has been completed based on the above findings.

【0006】[0006]

【課題を解決するための手段】即ち、本発明によれば、
カチャンヒジャ精製蛋白質を乾燥重量基準で1〜20重
量%含有する経腸栄養剤、より詳しくは乾燥重量基準で
炭水化物40〜95重量%、脂肪0〜20重量%及び上
記カチャンヒジャ精製蛋白質を含む総蛋白質5〜40重
量%を含有するカチャンヒジャ精製蛋白質含有経腸栄養
剤及び上記カチャンヒジャ精製蛋白質量が総蛋白質の3
0〜100重量%である経腸栄養剤が提供される。
That is, according to the present invention,
Enteral nutritional supplement containing 1 to 20% by weight of Kachanhija purified protein on a dry weight basis, more specifically 40 to 95% by weight of carbohydrate, 0 to 20% by weight of fat on a dry weight basis and total protein 5 containing the Kachanhija purified protein. -40% by weight of Kachan Hija purified protein-containing enteral nutrition and Kachan Hija purified protein content of 3 of total protein
An enteral nutritional supplement is provided which is 0 to 100% by weight.

【0007】本発明経腸栄養剤に用いられるカチャンヒ
ジャ精製蛋白質は、大豆蛋白に匹敵する優れた栄養価を
有しており、そのアミノ酸組成も栄養補給のための蛋白
源として好ましい。
Kachanhija purified protein used in the enteral nutrition of the present invention has an excellent nutritional value comparable to soybean protein, and its amino acid composition is also preferable as a protein source for nutritional supplementation.

【0008】本発明経腸栄養剤は、上記カチャンヒジャ
精製蛋白質の利用に基づいて、患者に充分な蛋白源を補
給できるものであり、特に乳糖不耐症患者に対しても安
心して利用できる特徴があり、食感(味、臭等)面でも
特に不都合はなく、経鼻、経口投与等も充分に可能であ
る。特に本発明経腸栄養剤の利用によれば、アンバラン
スな食生活の改善、生体の活動に必要なエネルギー及び
栄養素(カロリー)の適正な補給が可能である。
The enteral nutritional supplement of the present invention can replenish a patient with a sufficient protein source based on the use of the above-mentioned purified protein of Kachanhija, and is particularly characterized in that it can be used with peace of mind even in patients with lactose intolerance. There is no particular inconvenience in terms of texture (taste, odor, etc.), and nasal administration and oral administration are also sufficiently possible. In particular, the use of the enteral nutritional product of the present invention makes it possible to improve the unbalanced diet and to appropriately supply energy and nutrients (calories) necessary for the activity of the living body.

【0009】以下、本発明に利用するカチャンヒジャ精
製蛋白質の製造につき詳述すれば、該精製蛋白質は、例
えばカチャンヒジャ(原料豆)を水浸漬し、摩砕、濾過
して得られる生豆乳の遠心分離上澄をスプレードライす
ることにより得られる。
The production of the purified protein of Kachanhija used in the present invention will be described in detail below. The purified protein is obtained by, for example, dipping Kachanhija (raw beans) in water, grinding and filtering, and centrifuging raw soymilk. Obtained by spray drying the supernatant.

【0010】ここで原料豆として用いられるカチャンヒ
ジャは、インドネシア緑豆とも呼ばれ、本発明者らの行
なった食品分析法に従う分析によれば、蛋白質25%
(重量%、以下同じ)、脂肪1.3%、炭水化物56.
6%、水分13.6%、灰分3.5%を含んでおり、ま
た100g中にリン498mg、鉄593mg、カルシ
ウム115mg、ナトリウム1.94mg、マグネシウ
ム180mg、塩素26mg等のミネラル(更に亜鉛3
6.3ppmをも含む)と共に、カロチン0.16m
g、レチノール90IU、ビタミンB1 0.58mg、
ビタミンB2 0.16mg、ビタミンB6 0.38m
g、ビタミンC12mg、ビタミンD190IU、ビタ
ミンE10.8mg、ニコチン酸2.12mg、葉酸
0.22mg等を含んでおり、その熱量は約341kc
al/100gである。その含有蛋白質量は、鶏卵の約
2倍強であり、これは蛋白素材として好適である。
Kachanhija, which is used as a raw material bean here, is also called as Indonesian mung bean, and according to the analysis according to the food analysis method conducted by the present inventors, 25% protein is contained.
(Wt%, the same below), fat 1.3%, carbohydrate 56.
It contains 6%, water content 13.6%, and ash content 3.5%, and minerals such as phosphorus 498 mg, iron 593 mg, calcium 115 mg, sodium 1.94 mg, magnesium 180 mg, chlorine 26 mg in 100 g (additionally zinc 3
Carotene 0.16m together with 6.3ppm)
g, retinol 90 IU, vitamin B 1 0.58 mg,
Vitamin B 2 0.16 mg, Vitamin B 6 0.38 m
g, vitamin C 12 mg, vitamin D 190 IU, vitamin E 10.8 mg, nicotinic acid 2.12 mg, folic acid 0.22 mg, etc., and the calorific value is about 341 kc.
It is al / 100g. Its protein content is about twice as high as that of chicken egg, which is suitable as a protein material.

【0011】上記原料豆の摩砕は、例えば原料豆の水浸
漬物(原料豆を該豆に対して約2倍量の水に約30分間
程度浸漬したもの)を、コロイドミル(例えば特殊機化
工業株式会社製)等を用いて、適宜に実施できる。
The above-mentioned raw material beans are ground by, for example, dipping the raw material beans in water (the raw material beans soaked in about twice the amount of the beans for about 30 minutes) with a colloid mill (for example, a special machine). Chemical Industry Co., Ltd.) and the like.

【0012】摩砕物からの生豆乳の分離は、例えばフィ
ルタープレス等を用いて、約2kg/cm2 程度の条件
下に実施できる。
Separation of raw soymilk from the ground product can be carried out, for example, by using a filter press or the like under a condition of about 2 kg / cm 2 .

【0013】上記で得られる生豆乳を例えば3000r
pmで5分間程度遠心分離することにより、澱粉画分と
上澄とを分離でき、かくして得られる上澄を所望の蛋白
質含有液として用い、これを例えばスプレードライ等に
より乾燥させることにより、目的とする本発明カチャン
ヒジャ精製蛋白質を収得できる。上記乾燥操作はまた真
空乾燥機、ドラムドライ等を用いて、40℃程度の温度
条件下に実施することもできる。
The raw soybean milk obtained above is used, for example, in 3000r.
The starch fraction and supernatant can be separated by centrifugation at pm for about 5 minutes, and the supernatant thus obtained is used as a desired protein-containing solution and dried by, for example, spray drying to obtain the purpose. The purified protein of the present invention can be obtained. The above drying operation can also be carried out under a temperature condition of about 40 ° C. by using a vacuum dryer, a drum dryer or the like.

【0014】かくして得られる本発明のカチャンヒジャ
精製蛋白質は、後記する特定のアミノ酸組成を有してい
る。尚、このアミノ酸組成は、上記精製物をアミノ酸自
動分析計(日本電気社製アミノ酸分析機、JLC−20
0A型使用)により測定したものであり、トリプトファ
ンは高速液体クロマトグラフィー分析による値である。
またこのアミノ酸組成は、本明細書を通じて同じ測定法
によるものとする。
The Kachanhija purified protein of the present invention thus obtained has a specific amino acid composition described below. The amino acid composition was obtained by analyzing the above purified product with an amino acid automatic analyzer (Amino Acid Analyzer manufactured by NEC Corporation, JLC-20).
It is the value measured by high-performance liquid chromatography analysis.
In addition, this amino acid composition is based on the same measurement method throughout this specification.

【0015】本発明経腸栄養剤は、上記カチャンヒジャ
精製蛋白質をその蛋白源の全部又はその一部として利用
することを必須として、他は通常のこの種経腸栄養剤と
同様にして調整することができる。その好ましい組成と
しては、乾燥物重量基準で例えば炭水化物40〜95重
量%、脂肪0〜20重量%、総蛋白質5〜40重量%を
含むもの、より好ましくは炭水化物60〜90重量%、
脂肪5〜15重量%、総蛋白質10〜25重量%を含む
ものを例示できる。殊に、本発明経腸栄養剤は、上記カ
チャンヒジャ精製蛋白質を総蛋白質の30〜100重量
%用いるのが好適である。
The enteral nutritional product of the present invention requires the use of the above-mentioned purified protein of Kachanhija as all or a part of the protein source, and is otherwise adjusted in the same manner as this type of enteral nutritional product. You can Its preferable composition is, for example, 40 to 95% by weight of carbohydrate, 0 to 20% by weight of fat, and 5 to 40% by weight of total protein, more preferably 60 to 90% by weight of carbohydrate, based on the dry matter weight.
Examples include those containing 5 to 15% by weight of fat and 10 to 25% by weight of total protein. In particular, it is preferable that the enteral nutritional supplement of the present invention uses 30 to 100% by weight of the above-mentioned purified protein of Kachanhija based on the total protein.

【0016】上記本発明経腸栄養剤において、利用され
る炭水化物、脂肪及び上記カチャンヒジャ精製蛋白質以
外の蛋白源としては、従来よりこの種経腸栄養剤に汎用
されている各種のものをいずれも利用できる。その例と
しては、炭水化物では、例えばグルコース、マルトー
ス、蔗糖、イソマルトース、マルトテトラオース、マル
トトリオース、マルトペンタオース、マルトヘキサオー
ス、乳糖、グリコーゲン、デキストリン、デンプン等の
単糖類、オリゴ糖類、多糖類等を、脂肪では、例えば米
脂、綿実油、コーン油、大豆油、オリーブ油、ヒマワリ
油、カカオ脂、ゴマ油、サフラワー油、落花生油、バタ
ー、ラード、ヤシ油、ナッツ油、パーム油、菜種油、中
鎖トリグリセリド(MCT)等を、他の蛋白質では、例
えばカゼイン、カゼインナトリウム、カゼインカルシウ
ム、酵素分解ゼラチン(水溶性ゼラチン)、カゼイン酵
素分解物、大豆蛋白、小麦蛋白、コーングルテンミー
ル、之等の酵素分解物等を、それぞれ例示できる。上記
の内で、炭水化物では、例えば米デキストリンが、脂肪
では、例えばコーン油が、他の蛋白質では、例えばカゼ
インナトリウムが特に好ましい。
In the above-mentioned enteral nutritional product of the present invention, as the carbohydrates, fats and protein sources other than the above-mentioned Kachanhija purified protein, any of various types conventionally used in this type of enteral nutritional product can be used. it can. Examples thereof include carbohydrates such as glucose, maltose, sucrose, isomaltose, maltotetraose, maltotriose, maltopentaose, maltohexaose, lactose, glycogen, dextrin, monosaccharides such as starch, oligosaccharides, and polysaccharides. Sugars and the like, in fat, for example, rice fat, cottonseed oil, corn oil, soybean oil, olive oil, sunflower oil, cocoa butter, sesame oil, safflower oil, peanut oil, butter, lard, palm oil, nut oil, palm oil, rapeseed oil. , Medium chain triglyceride (MCT), and other proteins, such as casein, sodium caseinate, calcium caseinate, enzymatically-degraded gelatin (water-soluble gelatin), enzymatically-degraded casein, soybean protein, wheat protein, corn gluten meal, etc. The enzymatic decomposition products and the like can be exemplified. Of the above, for carbohydrates, for example rice dextrin, for fats, for example corn oil, and for other proteins, for example sodium caseinate are particularly preferred.

【0017】本発明経腸栄養剤は、上記3者を必須成分
とする他に、必要に応じて一般的経腸栄養剤と同様にし
て、通常の各種添加物を更に添加配合することができ
る。該添加物としては、各種ビタミン類(ビタミンA、
ビタミンB1 、ビタミンB2 、ビタミンB6 、ビタミン
12、ビタミンC、ビタミンD、ビタミンE、ナイアシ
ン、葉酸、パントテン酸等)、ミネラル類(カルシウ
ム、鉄、カリウム、ナトリウム、マグネシウム、リン、
クロール等の塩類等)、合成及び天然香料、天然甘味料
(ソーマチン、ステビア等)及び合成甘味料(サッカリ
ン、チクロ等)、着色料、乳化剤、安定剤、防腐剤等を
例示できる。
In addition to the above-mentioned three essential components, the enteral nutritional product of the present invention may further contain various conventional additives in the same manner as a general enteral nutritional product, if necessary. . As the additive, various vitamins (vitamin A,
Vitamin B 1 , vitamin B 2 , vitamin B 6 , vitamin B 12 , vitamin C, vitamin D, vitamin E, niacin, folic acid, pantothenic acid, etc.), minerals (calcium, iron, potassium, sodium, magnesium, phosphorus,
Examples thereof include salts such as chlor, etc.), synthetic and natural flavors, natural sweeteners (thaumatin, stevia, etc.) and synthetic sweeteners (saccharin, cyclamate, etc.), colorants, emulsifiers, stabilizers, preservatives and the like.

【0018】本発明経腸栄養剤の調整方法も、通常のこ
の種経腸栄養剤と同様でよく、特に限定されるものでは
なく、例えば上記各成分を混合乳化する方法によること
ができる。より詳しくは、炭水化物や蛋白質等の水溶性
成分を水もしくは湯に溶解させた後、加熱し、これに脂
肪等の油溶性成分を加えて、必要に応じてレシチン、シ
ュガーエステル等の通常慣用される乳化剤を用いて、適
当な乳化機により乳化する方法を好ましい方法として例
示できる。
The method of preparing the enteral nutritional supplement of the present invention may be the same as the usual enteral nutritional supplement of this kind and is not particularly limited. For example, a method of mixing and emulsifying each of the above components may be used. More specifically, water-soluble components such as carbohydrates and proteins are dissolved in water or hot water, and then heated, and oil-soluble components such as fat are added to the mixture, and lecithin, sugar ester and the like are generally used as needed. As a preferable method, a method of emulsifying with an appropriate emulsifying machine using an emulsifier can be exemplified.

【0019】かくして調製される本発明経腸栄養剤は、
適当な容器に無菌充填されるか、或いは缶、レトルトパ
ウチ等に充填された後、常法に従い加熱殺菌(例えば1
20℃、20分間程度)して製品とすることができ、こ
れは直接又は適宜希釈して栄養補給剤として実用でき
る。
The enteral nutritional product of the present invention thus prepared is
After aseptically filling an appropriate container or filling a can, a retort pouch, etc., heat sterilization (for example, 1
The product can be obtained by subjecting it to 20 ° C. for about 20 minutes), which can be directly or appropriately diluted and put to practical use as a nutritional supplement.

【0020】その投与量は、1日成人1人当り約25%
(w/v%)の液状形態で約10〜50ml/kg、好
ましくは20〜35ml/kg程度の範囲から選択され
る量を目安とするのが適当であり、これはこれを適用さ
れる患者等に応じて適宜増減できる。
The dose is about 25% per adult per day.
It is appropriate that the amount selected from the range of about 10 to 50 ml / kg, preferably about 20 to 35 ml / kg in the liquid form (w / v%) is used as a guide, and this is the patient to whom this is applied. It can be increased or decreased depending on the situation.

【0021】[0021]

【発明の効果】本発明経腸栄養剤は、高蛋白、高カロリ
ーでしかも栄養バランスに優れており、腸管内での分解
(消化)吸収性もよく、下痢、嘔吐、吐気発生等の副作
用も殆どなく、所望の栄養状態改善効果を常に安定して
充分に発揮できる。またこれは点滴等の経静脈投与によ
る必要がなく、これに比してより生理的な経口、経鼻等
の経腸的投与が可能で、この経腸投与により、各種の患
者や健常人に、栄養補給食として適用できる。
INDUSTRIAL APPLICABILITY The enteral nutritional supplement of the present invention has a high protein content, a high calorie content and an excellent nutritional balance, is well decomposed (digested) and absorbed in the intestinal tract, and has side effects such as diarrhea, vomiting and nausea. There is hardly any, and the desired nutritional state improving effect can be always exerted stably and sufficiently. In addition, this does not require intravenous administration such as infusion, and compared to this, more physiological oral and enteral administration such as nasal administration is possible, and by this enteral administration, it can be applied to various patients and healthy individuals. Applicable as a nutritional supplement.

【0022】[0022]

【実施例】以下、本発明を更に詳しく説明するため、実
施例を挙げる。
EXAMPLES Examples will be given below to explain the present invention in more detail.

【0023】[0023]

【実施例1】本発明カチャンヒジャ蛋白精製物の調製 カチャンヒジャ(Kacang Hijiau 、学名:Phaseolus Ra
diatus L. )3.3kgを等量の水に加えて30分間浸
漬後、コロイドミル(特殊機化工業株式会社製)にて摩
砕(20000rpm)し、フィルター濾過により分離
して生豆乳12.115kgとオカラ3.116kgと
を得た。
Example 1 Preparation of Protein Purified Product of the Present Invention Kachan Hija (Scientific Name: Phaseolus Ra
diatus L.) 3.3 kg was added to an equal amount of water and immersed for 30 minutes, then ground (20,000 rpm) with a colloid mill (manufactured by Tokushu Kika Kogyo Co., Ltd.), separated by filter filtration, and separated into raw soymilk. 115 kg and 3.116 kg of Okara were obtained.

【0024】上記生豆乳を遠心分離(3000rpm、
5分間)して上澄10.997kgと澱粉画分とを分離
し、上澄の内9.790kgをスプレードライ(ポンプ
圧:5kg/cm2 、吸気:190℃、排気:100
℃)して、本発明のカチャンヒジャ精製蛋白質粉末58
1g(水分含量3.1%)を得た。
[0024] The raw soy milk was centrifuged (3000 rpm,
After 5 minutes, 10.997 kg of the supernatant and the starch fraction were separated, and 9.790 kg of the supernatant was spray-dried (pump pressure: 5 kg / cm 2 , intake: 190 ° C., exhaust: 100).
℃), and then the Kachanhija purified protein powder 58 of the present invention
1 g (water content 3.1%) was obtained.

【0025】また、上記澱粉画分より、これを50℃で
乾燥して、カチャンヒジャ精製澱粉粉末368g(水分
含量10.8%)を回収した。
The starch fraction was dried at 50 ° C. to recover 368 g of Kachanhija purified starch powder (water content 10.8%).

【0026】上記精製蛋白質粉末につき、アミノ酸分析
を行なった結果は次の通りであった。
The amino acid analysis results of the purified protein powder were as follows.

【0027】 アルギニン 4.72%(重量%、以下同じ) フェニルアラニン 4.19% イソロイシン 2.82% アラニン 2.82% グルタミン酸 11.8% アスパラギン酸 7.80% リジン 4.73% チロシン 2.02% メチオニン 0.88% グリシン 2.38% セリン 3.46% トリプトファン 0.71% ヒスチジン 1.94% ロイシン 5.28% バリン 3.61% プロリン 2.81% スレオニン 2.12% シスチン 0.34%Arginine 4.72% (wt%, same below) Phenylalanine 4.19% Isoleucine 2.82% Alanine 2.82% Glutamic acid 11.8% Aspartic acid 7.80% Lysine 4.73% Tyrosine 2.02 % Methionine 0.88% Glycine 2.38% Serine 3.46% Tryptophan 0.71% Histidine 1.94% Leucine 5.28% Valine 3.61% Proline 2.81% Threonine 2.12% Cystin 0.34 %

【0028】[0028]

【実施例2】本発明経腸栄養剤の調製 実施例1で得たカチャンヒジャ精製蛋白質を必須蛋白源
として用い、下記処方の本発明経腸栄養剤を調製した。
但し、各成分量は全組成物重量を100gとした時のg
数で表示する。
Example 2 Preparation of Enteral Nutritional Supplement of the Present Invention Using the purified protein of Kachanhija obtained in Example 1 as an essential protein source, an enteral nutritional supplement of the present invention having the following formulation was prepared.
However, the amount of each component is g when the total composition weight is 100 g.
Display as a number.

【0029】 米デキストリン 70.1g コーン油 9.3g カゼインナトリウム 8.5g カチャンヒジャ精製蛋白質 7.0g 塩化ナトリウム 1.0g 塩化カリウム 0.61g 硫化マグネシウム 0.62g グリセロリン酸カルシウム 0.85g コハク酸クエン酸鉄ナトリウム 0.025g シュガーエステル 0.2g 各種ビタミン類 注1) 水分その他 全体を100gとする
量 尚、上記各種ビタミン類 注1)は、次のものを示す。
Rice dextrin 70.1 g Corn oil 9.3 g Sodium casein 8.5 g Kachanhija purified protein 7.0 g Sodium chloride 1.0 g Potassium chloride 0.61 g Magnesium sulfide 0.62 g Calcium glycerophosphate 0.85 g Sodium iron citrate citrate 0.025g Sugar ester 0.2g Various vitamins Note 1) Moisture and other amounts of 100g as a whole The various vitamins Note 1) are as follows.

【0030】 ビタミンA 466IU ビタミンB1 0.23mg ビタミンB2 0.26mg ビタミンB6 0.47mg ビタミンB12 1.17μg ニコチン酸アミド 3.5mg 葉酸 0.12mg ビタミンC 11.66mg ビタミンD 46.6IU ビタミンE 9.32IU パントテン酸 2.33mg 即ち、上記所定量の炭水化物、蛋白質等の水溶性成分を
湯(50℃)に溶解させた後、同温度でこれに上記所定
量の脂肪等の油溶性成分及び乳化剤としてのシュガーエ
ステルを加え、混合物を乳化機(ガウリン社製)を用い
て乳化させて(3000ps)、本発明経腸栄養剤を調
製した。
Vitamin A 466 IU Vitamin B 1 0.23 mg Vitamin B 2 0.26 mg Vitamin B 6 0.47 mg Vitamin B 12 1.17 μg Nicotinamide 3.5 mg Folic acid 0.12 mg Vitamin C 11.66 mg Vitamin D 46.6 IU Vitamin E 9.32 IU Pantothenic acid 2.33 mg That is, the above-mentioned predetermined amount of water-soluble components such as carbohydrates and proteins were dissolved in hot water (50 ° C), and then the above-mentioned predetermined amount of fat and oil-soluble The components and sugar ester as an emulsifier were added, and the mixture was emulsified (3000 ps) using an emulsifying machine (manufactured by Gaulin) to prepare the enteral nutritional supplement of the present invention.

【0031】かくして得られた本発明経腸栄養剤は、以
下の電解質イオンを含み、またその炭水化物、脂肪及び
蛋白質重量比及び熱量比を有するものであった。
The thus-obtained enteral nutritional product of the present invention contained the following electrolyte ions and had the weight ratio of carbohydrates, fats and proteins and the calorific ratio.

【0032】 Na 590mg(25.6mEq) K 319mg( 8.2mEq) Ca 164mg( 8.2mEq) Mg 62mg( 5.1mEq) Cl 902mg(25.4mEq) P 221mg Cu 0.03mg(0.001mEq) Zn 0.85mg(0.026mEq) I 0.03mg(0.0002mEq) Fe 2.73mg(0.1mEq) Mn 0.03mg(0.001mEq) S 82mg 炭水化物 70.1g 280kcal 脂肪 9.3g 84kcal 蛋白質 14.0g 56kcal 合計 420kcal/100g 上記経腸栄養剤は、その200ml、500ml又は1
000mlを、例えばレトルト容器に充填し加熱滅菌し
て製品形態とされ、これは経口・経腸栄養剤として栄養
補給を要する患者に1日成人1人当り1000〜250
0mlの範囲で経腸投与され、充分な栄養補給効果を奏
し得る。
Na 590 mg (25.6 mEq) K 319 mg (8.2 mEq) Ca 164 mg (8.2 mEq) Mg 62 mg (5.1 mEq) Cl 902 mg (25.4 mEq) P 221 mg Cu 0.03 mg (0.001 mEq) Zn 0.85 mg (0.026 mEq) I 0.03 mg (0.0002 mEq) Fe 2.73 mg (0.1 mEq) Mn 0.03 mg (0.001 mEq) S 82 mg Carbohydrate 70.1 g 280 kcal Fat 9.3 g 84 kcal Protein 14. 0g 56kcal Total 420kcal / 100g The above-mentioned enteral nutritional supplement is 200 ml, 500 ml or 1
For example, 000 ml is filled in a retort container and sterilized by heating to obtain a product form, which is 1000 to 250 per adult per day for a patient who needs nutritional support as an oral / enteral nutritional supplement.
It can be administered enterally in the range of 0 ml, and can exert a sufficient nutritional supplementation effect.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】カチャンヒジャ(ファセオラス ラジアタ
ス)精製蛋白質を乾燥重量基準で1〜20重量%含有す
ることを特徴とする経腸栄養剤。
1. An enteral nutritional product characterized by containing 1 to 20% by weight of a purified protein of Cachanhija (Phaseolus radiatas) on a dry weight basis.
【請求項2】乾燥重量基準で炭水化物40〜95重量
%、脂肪0〜20重量%及びカチャンヒジャ精製蛋白質
を含む総蛋白質5〜40重量%を含有する請求項1に記
載のカチャンヒジャ精製蛋白質含有経腸栄養剤。
2. The enteral preparation containing the purified protein of Kachan Hija according to claim 1, which contains 40 to 95 wt% of carbohydrate, 0 to 20 wt% of fat and 5 to 40 wt% of total protein including Kachan hija purified protein on a dry weight basis. Nutritional supplement.
【請求項3】カチャンヒジャ精製蛋白質量が総蛋白質の
30〜100重量%である請求項1又は2に記載の経腸
栄養剤。
3. The enteral nutritional supplement according to claim 1 or 2, wherein the amount of purified protein of Kachanhija is 30 to 100% by weight of the total protein.
JP4340619A 1992-12-21 1992-12-21 Enteral nutrient Pending JPH06181718A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4340619A JPH06181718A (en) 1992-12-21 1992-12-21 Enteral nutrient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4340619A JPH06181718A (en) 1992-12-21 1992-12-21 Enteral nutrient

Publications (1)

Publication Number Publication Date
JPH06181718A true JPH06181718A (en) 1994-07-05

Family

ID=18338710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4340619A Pending JPH06181718A (en) 1992-12-21 1992-12-21 Enteral nutrient

Country Status (1)

Country Link
JP (1) JPH06181718A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137278A (en) * 2002-10-17 2004-05-13 Sudzucker Ag Mannheim Ochsenfurt Method for producing isomaltose-containing enteral nutriment
JPWO2006041173A1 (en) * 2004-10-12 2008-05-22 明治乳業株式会社 Enteral nutrition
CN104757615A (en) * 2014-03-27 2015-07-08 许金芹 Bean curd and eel healthy porridge
WO2015105138A1 (en) 2014-01-09 2015-07-16 不二製油株式会社 Mung bean protein composition
CN116326784A (en) * 2023-04-20 2023-06-27 广州景腾医疗科技股份有限公司 Preparation method of soybean-based protein type nutritional agent

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137278A (en) * 2002-10-17 2004-05-13 Sudzucker Ag Mannheim Ochsenfurt Method for producing isomaltose-containing enteral nutriment
JPWO2006041173A1 (en) * 2004-10-12 2008-05-22 明治乳業株式会社 Enteral nutrition
JP5285856B2 (en) * 2004-10-12 2013-09-11 株式会社明治 Enteral nutrition
WO2015105138A1 (en) 2014-01-09 2015-07-16 不二製油株式会社 Mung bean protein composition
JPWO2015105138A1 (en) * 2014-01-09 2017-03-23 不二製油株式会社 Mung bean protein composition
EP3130229A4 (en) * 2014-01-09 2017-07-19 Fuji Oil Holdings Inc. Mung bean protein composition
US10362793B2 (en) 2014-01-09 2019-07-30 Fuji Oil Holdings Inc. Mung bean protein composition
CN104757615A (en) * 2014-03-27 2015-07-08 许金芹 Bean curd and eel healthy porridge
CN116326784A (en) * 2023-04-20 2023-06-27 广州景腾医疗科技股份有限公司 Preparation method of soybean-based protein type nutritional agent

Similar Documents

Publication Publication Date Title
RU2277354C2 (en) Food composition, method for production and uses thereof
CN1104855C (en) Composition and its use as food supplement or for lowering lipids in serum
Cheftel Nutritional effects of extrusion-cooking
Joanne Slavin PhD Nutritional benefits of soy protein and soy fiber
US20150079235A1 (en) Hemp-Based Infant Formula and Methods of Making Same
JP2599400B2 (en) Formulated liquid nutritional composition for glucose intolerant patients
CN108771221A (en) A kind of weight losing meal-replacing milk shake of nutrient protein
US5186963A (en) Therapeutic dietary composition containing amaranth
AU4300897A (en) Nutritional formula for phenylketonuria patients
Sajilata et al. Weaning foods: a review of the Indian experience
CN1134227C (en) Method for providing glutamine
CN101569410A (en) Special meal nutritional foods used by tumor patients
US6923995B2 (en) Rice protein concentrate based organic nutritional formula
EP2869707A1 (en) Method for producing a protein and lipid comprising composition with reduced digestive coagulation
JPH06181718A (en) Enteral nutrient
MXPA06013015A (en) Novel process for the manufacture and stability of a nutritional amaranth product.
KR100351669B1 (en) Noodle containing milk and method for manufacturing the same
Swaminathan Oilseed and nut proteins
Westerman et al. Improving the Nutritive Value of Flour: VII. Supplementing the Protein in Flour with Amino Acids
Kaur Medical foods from natural sources
US20230357335A1 (en) Low molecular weight protein compositions
EP4066892A1 (en) Composition for enteral intake
CN101461481A (en) Health-care tonic food and processing method
Ashur Nitrogen retention of adult human subjects who consumed combinations of wheat and rice supplemented with chickpea, sesame meal, milk or whey
CN110432427A (en) It is a kind of to help meal prepackaged food rich in balanced nutritious